Company description

Syneos Health is a leading global contract research and commercial services organisation headquartered in Morrisville, North Carolina. The company supports pharmaceutical, biotechnology and medical technology organisations across the entire product lifecycle, from early clinical development through to market access and commercialisation.

Formed in 2018 through the merger of INC Research and inVentiv Health, Syneos Health combines contract research organisation (CRO) capabilities with contract commercial organisation (CCO) and consulting services. This integrated model enables the company to deliver end-to-end support, aligning clinical development with market strategy to accelerate the delivery of therapies to patients.

The organisation positions itself as a “fully integrated biopharmaceutical solutions” provider, leveraging clinical, medical affairs and commercial insights to address complex market and regulatory challenges. By combining data, technology and therapeutic expertise, Syneos Health helps clients optimise development pathways and improve the likelihood of regulatory and commercial success.

With a workforce of over 25,000 professionals operating across more than 100 countries, the company supports a wide range of therapeutic areas including oncology, neuroscience, immunology and rare diseases. Its global footprint and multidisciplinary expertise enable it to work with clients ranging from emerging biotech firms to large multinational pharmaceutical companies.

Key products and services

Clinical development (CRO services)

• Full-service clinical trial management (Phase I–IV)

• Early-phase and specialised trials (e.g. oncology, neuroscience)

• Patient recruitment, site management and data collection

• Biostatistics, regulatory support and trial optimisation

Safety and pharmacovigilance

• Global drug safety monitoring and reporting

• Pre- and post-marketing pharmacovigilance services

• Risk management and regulatory compliance solutions

Consulting and strategic advisory

• Market access and pricing strategy

• Commercial planning and product positioning

• Real-world evidence and healthcare analytics

Commercialisation services (CCO)

• Sales force deployment and field support

• Medical affairs and scientific communications

• Brand strategy, marketing and patient engagement

Integrated biopharmaceutical lifecycle support

• End-to-end solutions from clinical development to product launch

• Data-driven insights combining clinical and commercial intelligence

• Customised outsourcing models for pharma and biotech clients

By integrating clinical research, consulting and commercial capabilities within a single operating model, Syneos Health enables pharmaceutical and biotechnology companies to streamline development and accelerate market entry. Its ability to connect scientific, regulatory and commercial insights positions the company as a strategic partner for organisations seeking to bring innovative therapies to patients more efficiently and successfully.